Who are the key players in North America Blood Screening Market industry?

The top five players in the North America Blood Screening Market include Roche Diagnostics, Abbott Laboratories, Grifols S.A., Bio-Rad Laboratories, and Siemens Healthineers. These companies dominate the market due to their strong product portfolios, innovative screening technologies, broad distribution networks, and ongoing investments in research and development.

What is the North America Blood Screening Market growth?

The North America Blood Screening Market is experiencing robust growth, with recent estimates suggesting a CAGR of around 7% from 2023 to 2028. Growth is driven by increasing demand for early disease detection, with companies like Abbott Laboratories introducing advanced molecular testing solutions to enhance screening accuracy and efficiency.

Which segment accounted for the largest North America Blood Screening Market share?

The largest market share within the North America Blood Screening Market is held by the blood banks application segment. This dominance is supported by rising donations and stringent screening protocols to prevent transfusion-transmissible infections, ensuring safe blood supply for critical healthcare needs across hospitals and clinics.

What are the factors driving the North America Blood Screening Market?

Key factors driving this market include increasing prevalence of infectious diseases, supportive government regulations, and technological advancements. For example, Roche Diagnostics has invested in automation and high-throughput screening platforms, improving turnaround times and accuracy in blood testing, which fuels market expansion.

Which type accounted for the largest North America Blood Screening Market share?

Nucleic Acid Testing (NAT) accounted for the largest share in the North America Blood Screening Market. NAT's high sensitivity and ability to detect viral genetic material at early stages of infection make it the preferred method for screening blood donations and safeguarding transfusion procedures.

Home Healthcare

North America Blood Screening Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America Blood Screening Market
Brand: Bussiness Insights

North America Blood Screening Market: by Type (Reagent & Kits, Instruments, Software & Services), Application (Blood Transfusion, Infection Detection, Disease Prevention & Control, Blood Donations, Research Application), Distribution Channels (Hospitals, Blood Banks, Diagnostic Centers, Clinics, Research Institutes, Others), Technology (Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay, Rapid Tests, Western Blot Assay, Next-Generation Sequencing, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20264 | Author: Abhishek

RD TOC Segmentation Research Methodology Request For Free Sample

North America Blood Screening Market Size, Share & Forecast (2020-2035)

The North America Blood Screening Market is witnessing significant growth propelled by the heightened focus on blood safety, technological innovations in diagnostics, and a consistently high volume of blood transfusions and donations. The market landscape is increasingly shaped by advanced molecular assay methods, regulatory compliance, and the growing adoption of next-generation sequencing for early infection detection. With the presence of leading manufacturers and ongoing R&D activity, the region dominates the global blood screening sector, and this trajectory is sustained by robust investments from both private and public entities. By 2025, the market growth is expected to continue with rising awareness for disease prevention and stringent quality standards in healthcare. Key sectors driving demand include hospitals, blood banks, and diagnostic centers, supported by major industry players advancing automation and molecular diagnostics.

Latest Market Dynamics

Key Drivers

Technological advancements in blood screening, such as the deployment of automated nucleic acid testing (NAT) platforms, are accelerating early detection of infectious diseases. In 2024,

Integration of artificial intelligence and digital health tools to streamline laboratory workflows is a key trend. In 2024, Bio-Rad Laboratories introduced AI-powered platforms that optimize results interpretation and process management in blood testing.
Growing adoption of multiplex assays and next-generation sequencing (NGS) for multi-pathogen detection is rising. Roche, in June 2024, launched enhanced NGS panels for simultaneous screening of various transfusion-transmissible infections.

Expansion into point-of-care testing with portable rapid test devices creates new market avenues. Thermo Fisher Scientific, in July 2024, launched portable NAT systems targeting rural clinics and emergency transfusion units.
Collaborations with public health bodies to implement mass blood screening during outbreaks provide growth prospects. Siemens Healthineers partnered with Canadian authorities in June 2024 to deploy emergency infection surveillance kits.

In 2025, Reagent & Kits are expected to dominate the North America Blood Screening Market by type, representing the largest portion of usage due to their critical role in routine testing processes. Instruments, which are essential for automating and streamlining laboratory workflow, are projected to be the second-largest segment. Software & Services cover solutions for data management and result analysis, reflecting the growing focus on digitalization in diagnostics. This distribution highlights a balanced adoption of consumables and technology, driven by ongoing efforts to improve efficiency, accuracy, and compliance in blood screening.

Blood transfusion application constitutes the largest market share in the North America Blood Screening Market for 2025, driven by the region’s high demand for safe and efficient transfusion services. Infection detection remains the second-largest application, reflecting growing necessity to prevent transmissible diseases through rigorous screening protocols. Disease prevention and control account for a significant segment, highlighting increased awareness and initiatives in public health safety. The application mix is a clear indicator of the region’s strong focus on quality healthcare delivery and infection control across a range of medical and research settings.

The North America Blood Screening Market is projected to grow steadily from 2020 to 2035, with revenue increasing from 2,720 million USD in 2020 to approximately 4,800 million USD by 2035. This upward trend is supported by the continual introduction of advanced screening technologies and rising awareness about blood-borne infections. Market expansion is particularly marked in the post-pandemic years, reflecting renewed investments in healthcare infrastructure and digital transformation in diagnostics. The robust CAGR throughout the period indicates sustainable demand growth and technological progress within the screening segment.

Year-on-year growth rates for the North America Blood Screening Market are projected to maintain a stable curve from 2020 to 2035. The market experienced a significant jump of 7.1% in 2021, boosted by a post-pandemic increase in blood donations and testing. Annual growth is forecasted to stabilize at around 5.5% through 2025–2030, gradually tapering to 4.2% by 2035 as the market matures and penetrates deeper into hospital and outpatient settings. Sustained investments and a steady stream of technological breakthroughs are expected to reinforce the market’s positive growth trajectory throughout the forecast period.

In 2025, the United States will continue to be the dominant region in the North America Blood Screening Market, accounting for the majority of the market share owing to its extensive healthcare infrastructure and high testing volume. Canada follows as the second-largest contributor, benefitting from increased investment in healthcare modernization and strong public health initiatives. Mexico, while smaller, is experiencing the fastest growth due to public health campaigns and improving access to advanced screening methods. This distribution underscores the disparity in healthcare capacity yet highlights the overall regional progress in ensuring safer blood supplies.

Abbott Laboratories leads the North America Blood Screening Market in 2025 due to its diversified product offerings and rapid deployment of automated solutions. Grifols S.A. and F. Hoffmann-La Roche AG also command significant shares, with strong pipelines and strategic partnerships within healthcare institutions. Other notable contributors include Bio-Rad Laboratories and BD, while the remainder is shared among specialized and regional players. The competitive landscape is distinguished by intensive R&D, robust mergers & acquisitions, and rapid technological innovation, all serving to maintain market dynamism.

The highest proportion of blood screening market purchases in North America in 2025 is attributed to hospitals, reflecting their central role in patient care and transfusion services. Blood banks are responsible for the second-largest share, catering to both donation and storage needs, followed by diagnostic centers which have expanded their screening services with the latest molecular technologies. This segmentation highlights the broadening use of screening products across diversified healthcare settings, underpinned by an urgent focus on safety, efficiency, and regulatory compliance.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	3400
Regions	United States, Canada, Mexico
Segments	Reagent & Kits, Instruments, Software & Services, Accessories, Consumables, Others; Blood Transfusion, Infection Detection, Disease Prevention & Control, Blood Donations, Research Application, Others
Players	Abbott Laboratories, Grifols S.A., Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Ortho Clinical Diagnostics, bioMérieux SA, DiaSorin S.p.A., PerkinElmer Inc., Enzo Biochem Inc., Trinity Biotech Plc, Merck KGaA

June 2024: Abbott Laboratories announced the commercial release of the Alinity m Blood Screening System with AI integration to improve infectious disease detection accuracy.
July 2024: Thermo Fisher Scientific launched its GeneSwitch Portable NAT system for rapid point-of-care blood testing in rural and emergency settings.
June 2024: Siemens Healthineers began collaboration with Public Health Agency of Canada to deploy blood screening kits for infectious disease outbreak response.
August 2024: Roche introduced updated NGS panels for faster, multi-pathogen blood screening in high-throughput labs across North America.
July 2024: Grifols S.A. expanded its blood bank automation suite with scalable software for large institutional networks in the United States and Canada.

About the Author

Abhishek

Senior Market Research Analyst

Abhishek is a Senior Market Research Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Abhishek brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Abhishek has helped organizations translate data into actionable growth strategies.

HealthcareMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

North America Blood Screening Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America Blood Screening Market Size, Share & Forecast (2020-2035)

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

Market Share by Type, 2025

Market Share by Application, 2025

Market Revenue by Year (2020–2035)

Year-on-Year Growth Rate (%) (2020–2035)

Market Share by Region, 2025

Market Share by Leading Players, 2025

Market Share by Buyer Type, 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports